Document is current
Any future updates will be listed below
-
Authors
Kennedy, Aidan M. https://orcid.org/0009-0000-6186-5348
Murad, Andrea M. https://orcid.org/0000-0003-0423-4966
Koeppe, Erika S. https://orcid.org/0000-0002-9775-6327
Riba, Michelle B. https://orcid.org/0000-0002-0232-6069
Stoffel, Elena M. https://orcid.org/0000-0002-5637-3418
Jacobs, Michelle F. https://orcid.org/0000-0002-0458-1952
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 16 April 2025
First Online: 26 April 2025
Declarations
:
: This was secondary research for which informed consent is not required, based on meeting Federal Exemption #4, 3rd criteria: HIPAA Exemption. The research involved only information collection and analysis involving the investigator’s use of identifiable health information when that use is regulated under 45 CFR parts 160 and 164, subparts A and E, for the purposes of “health care operations” or “research” as those terms are defined at 45 CFR 164.501.
: Dr. Michelle Riba has served on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Distress Management panel since 1998 and has been Chair since 2018. The other authors have no conflicts of interest related to this work.
